GNS.L vs NEOG
GNS.L: A global leader in animal genetics, using biotechnology to improve the quality and efficiency of livestock production. NEOG: Neogen provides essential diagnostic and safety solutions to protect the global food supply chain and enhance animal health and welfare.
Side-by-side fundamentals
| Metric | GNS.L | NEOG | Edge |
|---|---|---|---|
| Price as of 2026-08-07 close | £23.04 | $11.47 | |
| Market cap as of 2026-08-09 | n/a | $2.5B | |
| Net margin as of 2026-08-09 | n/a | -0.9% | |
| Gross margin as of 2026-08-09 | n/a | +46.9% | |
| Operating margin as of 2026-08-09 | n/a | +6.3% | |
| ROE as of 2026-08-09 | n/a | -0.4% | |
| ROA as of 2026-08-09 | n/a | -0.2% | |
| Debt / equity as of 2026-08-09 | n/a | 0.38 | |
| Revenue growth (YoY) as of 2026-08-09 | n/a | -2.7% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +1.9% | |
| Beta as of 2026-08-09 | n/a | 1.82 | |
| 1-year return as of 2026-08-07 close | -8.0% | +129.4% | NEOG higher |
Fundamentals: market data, as of 2026-08-09. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.